Compare QNCX & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | SANG |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 170.0M |
| IPO Year | 2019 | 2021 |
| Metric | QNCX | SANG |
|---|---|---|
| Price | $2.81 | $5.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 698.3K | 3.7K |
| Earning Date | 11-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $227,360,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $4.08 |
| 52 Week High | $4.55 | $7.99 |
| Indicator | QNCX | SANG |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 46.23 |
| Support Level | $3.18 | $4.80 |
| Resistance Level | $3.38 | $5.08 |
| Average True Range (ATR) | 0.27 | 0.14 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 6.51 | 39.62 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.